Diligence memo · auto-generated · as of July 3, 2026

Roxwood Medical, Inc.

Roxwood Medical, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Roxwood Medical, Inc. operates in Other, based in REDWOOD CITY.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Roxwood Medical, Inc. has raised $10M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.5M on 2015-05-04.

Most recent recorded round closed around 2015-05-04.

Valuation (modeled)modeled

Provath models Roxwood Medical, Inc. at approximately $98M (range $8.8M–$532M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.11× the median modeled value of Series A Other companies in 2013–2015 (623 peers) — value vs value, same stage and era. Within the normal band (111% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 11.2 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.6× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 78% of Other peers (25015 compared).

Modeled value ranks above 83% of those peers.

Closest niche peers: Biloxi Baseball, LLC, United Sample Inc, Revolution Lighting Technologies, Inc., County Waste of Virginia, LLC, Marathon Patent Group, Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.